# Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer

> **NCT00954278** · PHASE1 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 24 (actual)

## Conditions studied

- Carcinoma, Non Small Cell Lung

## Interventions

- **DRUG:** sorafenib

## Key facts

- **NCT ID:** NCT00954278
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07-28
- **Primary completion:** 2015-12-23
- **Final completion:** 2015-12-23
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00954278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00954278, "Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00954278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*